|
|
Induced and spontaneous abortion and breast cancer risk: results from the E3N cohort study.
Xavier Paoletti
,
Françoise Clavel-Chapelon
Article dans une revue
inserm-00127741v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial
Christophe Le Tourneau
,
Maud Kamal
,
Olivier Trédan
,
Jean-Pierre Delord
,
Mario Campone
,
et al.
Article dans une revue
istex
inserm-02294308v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Dealing with missing data in the Center for Epidemiologic Studies Depression self-report scale: a study based on the French E3N cohort.
Noémie Resseguier
,
Hélène Verdoux
,
Roch Giorgi
,
Françoise Clavel-Chapelon
,
Xavier Paoletti
Article dans une revue
inserm-00802496v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial : idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma
Amélie Anota
,
Mathieu Boulin
,
Sandrine Dabakuyo-Yonli
,
Patrick Hillon
,
Jean-Pierre Cercueil
,
et al.
Article dans une revue
hal-01384670v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Dose-finding design using mixed-effect proportional odds model for longitudinal graded toxicity data in phase I oncology clinical trials.
Adélaïde Doussau
,
Rodolphe Thiébaut
,
Xavier Paoletti
Article dans une revue
istex
hal-00936325v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Dose finding with longitudinal data: simpler models, richer outcomes
Xavier Paoletti
,
Adélaïde Doussau
,
Monia Ezzalfani
,
Elisa Rizzo
,
Rodolphe Thiébaut
Article dans une revue
istex
hal-01288874v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Serious psychiatric outcome of subjects prenatally exposed to diethylstilboestrol in the E3N cohort study.
Hélène Verdoux
,
Jacques Ropers
,
Dominique Costagliola
,
Françoise Clavel-Chapelon
,
Xavier Paoletti
Article dans une revue
inserm-00145139v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials
F. Bonnetain
,
Xavier Paoletti
,
S. Collette
,
M. Doffoel
,
O. Bouché
,
et al.
Quality of Life Research, 2008, 17 (6), pp.831-843
Article dans une revue
hal-00363732v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19).
Astrid Lièvre
,
Anthony Turpin
,
Isabelle Ray-Coquard
,
Karine Le Malicot
,
Juliette Thariat
,
et al.
Article dans une revue
hal-02998283v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study.
Estelle Gauthier
,
Xavier Paoletti
,
Françoise Clavel-Chapelon
Article dans une revue
inserm-00127779v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting.
C. Tournoux-Facon
,
Xavier Paoletti
,
Barbare J.C.
,
O. Bouché
,
P. Rougier
,
et al.
Journal of Hepatology, 2011, 54 (1), pp.108-114
Article dans une revue
hal-00584929v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Predictive value of intratumoral signaling and immune infiltrate in primary breast cancer (PBC) for response to preoperative trastuzumab (T) vs trastuzumab + everolimus (T+E) in patients (pts) with early breast cancer (BC) : Unicancer RADHER trial results
Mario Campone
,
Isabelle Treilleux
,
Julia Salleron
,
Monica Arnedos
,
Qing Wang
,
et al.
ASCO 2016 annual meeting, Jun 2016, Chicago, IL, United States. pp.abstr 606
Communication dans un congrès
hal-01320584v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Dose-finding methods: Moving away from the 3+3 to include richer outcomes Running
Xavier Paoletti
,
Damien Drubay
,
Laurence Collette
Article dans une revue
inserm-01542704v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials
S. Collette
,
F. Bonnetain
,
Xavier Paoletti
,
M. Doffoel
,
O. Bouché
,
et al.
Annals of Oncology, 2008, 19 (6), pp.1117-1126
Article dans une revue
hal-00363734v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer
Yann Neuzillet
,
Xavier Paoletti
,
Slah Ouerhani
,
Pierre Mongiat-Artus
,
Hany Soliman
,
et al.
Article dans une revue
hal-01358546v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
Perrine Vuagnat
,
Maxime Frelaut
,
Toulsie Ramtohul
,
Clémence Basse
,
Sarah Diakité
,
et al.
2020
Pré-publication, Document de travail
hal-02559160v2
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials
Adélaide Doussau
,
Rodolphe Thiebaut
,
B. Geoerger
,
Patrick Schoffski
,
Anne Floquet
,
et al.
Article dans une revue
hal-01288869v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|
|
|
Designs for evaluating precision medicine trials
Xavier Paoletti
,
Bernard Asselain
,
Christophe Le Tourneau
Pan-cancer Integrative Molecular Portrait Towards a New Paradigm in Precision Medicine, pp.113-131, 2015, 9783319221892. ⟨10.1007/978-3-319-22189-2_8⟩
Chapitre d'ouvrage
hal-02560954v1
|
Partager
Gmail
Facebook
X
LinkedIn
More
|